DIRECTOR
:
SPEAKER
(S):
Nicolas Pineault, PhD, Scientist, Hema-Quebec
A cellular based therapy to prevent or reduce thrombocytopenia
Kent Christopherson, II, PhD, Associate Professor, Rush University Medical Center
Improving the Efficiency of Hematopoietic Stem Cell Transplantation by Targeting Chemokine Amino-Terminal Proteolytic Processing
Cheryl Lobo, PhD, New York Blood Center
Description
This program showcases the research activities of three early-career transfusion medicine investigators who have leveraged NBF seed grant funding into a high-profile career in transfusion medicine and cellular therapies research. The Pall Prize will also be awarded at this luncheon to innovative and creative research that may ultimately lead to improving transfusion medicine outcomes. Enjoy a delicious lunch while the scientists discuss their latest research with a focus on the role their findings will play in driving the future of transfusion medicine and cellular therapies. Time for questions and informal discussion is provided.
-
Assess and appreciate how NBF-funded exploratory research activities have driven developments that improve patient and donor care.
-
Describe cutting-edge discoveries that will shape transfusion medicine and cellular therapies in the future.
-
Discover how the NBF Scientific Research Grants Program has helped early-career investigators develop transfusion medicine and cellular therapies research.
CE Category | CE Value |
---|
California Clinical Laboratory Personnel |
2 |
California Nurse |
2.4 |
Florida Laboratory Personnel |
2.4 |
General Attendee |
2 |
Physician |
2 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.